Huntsman (HUN)
(Delayed Data from NYSE)
$25.13 USD
-0.09 (-0.36%)
Updated May 15, 2024 04:00 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Brokerage Reports
Huntsman Corporation [HUN]
Reports for Purchase
Showing records 181 - 200 ( 461 total )
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Chemicals 3Q Preview: Upgrade CE to OW; Prefer Intermediates, Specialties, and Ag to Ethylene Names
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Management Meetings Takeaways; Reiterate Overweight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Updated 3Q Guide Highlights MDI Strength and Cycle Prospects; Raise PT to $29
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
We See Sale of VNTR Stake Positively; Lowers Leverage and Risk
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Chemicals: MDI Margins Rise Meaningfully in Europe, Asia in August
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
2Q20 First Look - Upside to 3Q20 Consensus Likely
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
2Q20 Follow Up Positives Outweigh Negatives; Remain OW as We See Stock Priced for Endless Trough
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department